Four biotech companies are forming a coalition to advocate for manufacturing pharmaceutical products within the United States.
The Securing America’s Medicines and Supply coalition (SAMS) is composed of Coherus BioSciences, Teva Pharmaceutical Industries, Zymergen, and iRemedy Healthcare Companies. The group aims to boost the U.S. supply chain while also fostering cooperation with U.S. allies to “near shore” pharmaceuticals and medical supplies.
“Together, we can help Congress and the Administration do the hard work to cure and secure our medical supply chain through a coordinated approach that boosts American and ally production — and rewards quality and innovation,” SAMS Executive Director David Sanders said in a statement. “A diversified and dependable supply chain needs to be expanded and right-sized for U.S. patients.”